Mezni, E.; Vicier, C.; Guerin, M.; Sabatier, R.; Bertucci, F.; Gonçalves, A.
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices? Cancers 2020, 12, 1573.
https://doi.org/10.3390/cancers12061573
AMA Style
Mezni E, Vicier C, Guerin M, Sabatier R, Bertucci F, Gonçalves A.
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices? Cancers. 2020; 12(6):1573.
https://doi.org/10.3390/cancers12061573
Chicago/Turabian Style
Mezni, Essia, Cécile Vicier, Mathilde Guerin, Renaud Sabatier, François Bertucci, and Anthony Gonçalves.
2020. "New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?" Cancers 12, no. 6: 1573.
https://doi.org/10.3390/cancers12061573
APA Style
Mezni, E., Vicier, C., Guerin, M., Sabatier, R., Bertucci, F., & Gonçalves, A.
(2020). New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices? Cancers, 12(6), 1573.
https://doi.org/10.3390/cancers12061573